We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$77.1B
AUM Growth
-$1.68B
(-2.1%)
Cap. Flow
-$2.68B
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Snap-on
SNA
$21.7B
| $281K | ﹤0.01% |
775
-28,116
| -97% | -$10.4M |
|
2502
West Pharmaceutical
WST
$23.7B
| $281K | ﹤0.01% |
1,121
-54
| -5% | -$13.4K |
|
2503
TKO Group
TKO
$13.9B
| $279K | ﹤0.01% |
1,384
-14,995
| -92% | -$3.07M |
|
2504
N-able
NABL
$818M
| $279K | ﹤0.01% |
+59,748
| New | +$334K |
|
2505
Home BancShares
HOMB
$6.31B
| $279K | ﹤0.01% |
10,343
-11,766
| -53% | -$331K |
|
2506
F5
FFIV
$22.8B
| $278K | ﹤0.01% |
962
-22,885
| -96% | -$6.35M |
|
2507
PUT
Sysco
SYY
$40.7B
| $278K | ﹤0.01% |
+3,900
| New | +$322K |
|
2508
Smith & Wesson
SWBI
$657M
| $278K | ﹤0.01% |
19,404
-56,225
| -74% | -$683K |
|
2509
Indivior Pharmaceuticals
INDV
$4.85B
| $278K | ﹤0.01% |
+9,121
| New | +$301K |
|
2510
Shenandoah Telecom
SHEN
$655M
| $278K | ﹤0.01% |
+18,008
| New | +$236K |
|
2511
Charter Communications
CHTR
$16.7B
| $277K | ﹤0.01% |
1,285
-3,023
| -70% | -$655K |
|
2512
United Bankshares
UBSI
$6.71B
| $277K | ﹤0.01% |
6,678
-8,783
| -57% | -$365K |
|
2513
RxSight
RXST
$250M
| $276K | ﹤0.01% |
44,793
-37,043
| -45% | -$308K |
|
2514
Alliant Energy
LNT
$19.1B
| $275K | ﹤0.01% |
3,837
-10
| -0.3% | -$690 |
|
2515
Washington Trust Bancorp
WASH
$754M
| $274K | ﹤0.01% |
+8,196
| New | +$270K |
|
2516
Republic Bancorp
RBCAA
$1.97B
| $274K | ﹤0.01% |
+3,887
| New | +$274K |
|
2517
Amcor
AMCR
$21.6B
| $274K | ﹤0.01% |
6,896
-13
| -0.2% | -$575 |
|
2518
SBA Communications
SBAC
$18.6B
| $274K | ﹤0.01% |
1,590
-317,878
| -100% | -$59.6M |
|
2519
AnaptysBio
ANAB
$1.54B
| $272K | ﹤0.01% |
+4,905
| New | +$264K |
|
2520
Axos Financial
AX
$5.64B
| $272K | ﹤0.01% |
3,195
-3,879
| -55% | -$354K |
|
2521
Mid-America Apartment Communities
MAA
$15.8B
| $272K | ﹤0.01% |
2,225
-426,786
| -99% | -$56.3M |
|
2522
Howard Hughes
HHH
$4B
| $270K | ﹤0.01% |
+4,266
| New | +$320K |
|
2523
Sabra Healthcare REIT
SBRA
$5.61B
| $269K | ﹤0.01% |
14,004
-1,902,251
| -99% | -$37.5M |
|
2524
Nuvation Bio
NUVB
$2.33B
| $268K | ﹤0.01% |
+62,521
| New | +$348K |
|
2525
Genco Shipping & Trading
GNK
$1.11B
| $268K | ﹤0.01% |
11,864
-17,988
| -60% | -$385K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.
- Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
- Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.